In the BioHarmony Drug Report Database
Ifosfamide
Ifex (ifosfamide) is a small molecule pharmaceutical. Ifosfamide was first approved as Ifex on 1988-12-30. It is used to treat b-cell chronic lymphocytic leukemia, breast neoplasms, hodgkin disease, lung neoplasms, and non-hodgkin lymphoma amongst others in the USA.
Trade Name
|
Ifex |
|---|---|
Common Name
|
ifosfamide |
ChEMBL ID
|
CHEMBL1024 |
Indication
|
b-cell chronic lymphocytic leukemia, breast neoplasms, hodgkin disease, lung neoplasms, non-hodgkin lymphoma, ovarian neoplasms, pancreatic neoplasms, precursor cell lymphoblastic leukemia-lymphoma, sarcoma, stomach neoplasms, testicular neoplasms |
Drug Class
|
Phosphoro-derivatives; isophosphoramide mustard derivatives |
Image (chem structure or protein)